Thursday's top analyst upgrades and downgrades included Best Buy, Booking, ConocoPhillips, CRISPR Therapeutics, Fisker, Halliburton, Lordstown Motors, RH, Tesla, Walt Disney and Zscaler.
Lipocine shares absolutely plummeted on Monday after the firm announced that it received a Complete Response Letter from the FDA regarding its New Drug Application for Tlando.
Wednesday was a relatively positive day for the broad U.S. markets. We are now reaching the point in earnings season where more retailers will be reporting. Walmart led the Dow to start the truncated...
GE is dropped from the Dow Jones industrial average, Volkswagen and Ford may build new cars together, and other important headlines.
Tuesday was another down day for the broad U.S. markets, with all major exchanges taking a step back. Crude oil recovered backed off again and is hovering just above $65. The S&P 500 sectors were...
CVS Health will give its workers raises, Facebook is trying out a new negative comment project, MoviePass is growing quickly, and other important headlines.
The top analyst upgrades, downgrades and other research calls from Friday include Boston Scientific, Ciena, GoDaddy, Kratos Defense, Lipocine, Repligen, Teladoc and Vodafone.
Apple may enjoy a massive tax windfall under the new tax code, UPS warns some holiday deliveries could be delayed, and other important headlines.
The top analyst upgrades, downgrades and other research calls from Monday include Blue Apron, Broadcom, Charter Communications, CVS Health, Delphi, eBay, Rite Aid and UPS.
CVS Healthcare will buy Aetna, Broadcom wants to buy rival Qualcomm, economists believe growth of the U.S. economy will be stronger than they had expected, and more important headlines.
Amazon may buy one or more drug companies, GM will have a self-driving taxi in just over a year, CVS Health may buy Aetna, and more important headlines.
The top analyst upgrades, downgrades and other research calls from Friday include AMD, CVS Health, Disney, Fiat Chrysler, Kinross Gold, Kohl's and NVIDIA.
The top analyst upgrades, downgrades and other research calls from Tuesday include Altice USA, CVS Health, Exxon, Lowe's, T-Mobile, Sprint and Under Armour.
Google posted better-than-expected earnings, CVS Health is rumored to have made a bid for Aetna, Amazon may move into the wholesale drug business, and more important headlines.
The top analyst upgrades, downgrades and other research calls from Tuesday include Apple, Chesapeake Energy, DowDuPont, Equifax, Gap, Nike, Tesla and Under Armour.